Select Page

A global pharmaceutical company wanted to identify diagnostic technologies that would support the clinical development and commercial performance of agents targeting two infectious diseases and represent potential partnership opportunities.

Shift Health employed a multi-pronged research approach to build a robust understanding of disease management algorithms, standard-of-care and emerging diagnostic technologies as well as unmet patient needs. We developed and used a robust, customized evaluation framework to rank diagnostic technologies, enabling the client to prioritize diagnostic developers to engage in clinical development partnerships.

Shift Health’s recommendations positioned the client to refine its clinical and business development strategy to enhance the future commercial impact of the companies pre-market infectious disease assets.